Core Laboratories N.V.
CLB · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $134,521 | $130,159 | $123,585 | $129,237 |
| % Growth | 3.4% | 5.3% | -4.4% | – |
| Cost of Goods Sold | $108,495 | $107,371 | $103,186 | $109,863 |
| Gross Profit | $26,026 | $22,788 | $20,399 | $19,374 |
| % Margin | 19.3% | 17.5% | 16.5% | 15% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $10,688 | $10,464 | $13,647 | $9,080 |
| SG&A Expenses | $10,688 | $10,464 | $13,647 | $9,080 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$5,590 | -$2,967 | $2,335 | -$3,880 |
| Operating Expenses | $5,098 | $7,497 | $15,982 | $5,200 |
| Operating Income | $20,928 | $15,291 | $4,417 | $14,174 |
| % Margin | 15.6% | 11.7% | 3.6% | 11% |
| Other Income/Exp. Net | -$2,650 | -$2,711 | -$2,602 | -$2,629 |
| Pre-Tax Income | $18,278 | $12,580 | $1,815 | $11,545 |
| Tax Expense | $3,754 | $1,911 | $1,746 | $4,076 |
| Net Income | $14,239 | $10,636 | -$154 | $7,403 |
| % Margin | 10.6% | 8.2% | -0.1% | 5.7% |
| EPS | 0.3 | 0.22 | -0.003 | 0.16 |
| % Growth | 36.4% | 6,766.7% | -102.1% | – |
| EPS Diluted | 0.3 | 0.22 | -0.003 | 0.16 |
| Weighted Avg Shares Out | 47,078 | 47,509 | 46,773 | 46,827 |
| Weighted Avg Shares Out Dil | 47,078 | 47,509 | 46,773 | 47,773 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2,650 | $2,711 | $2,602 | $2,629 |
| Depreciation & Amortization | $3,594 | $7,387 | $3,717 | $3,664 |
| EBITDA | $24,522 | $22,645 | $8,097 | $17,838 |
| % Margin | 18.2% | 17.4% | 6.6% | 13.8% |